Utilizing Altmetrics to Track Advancements in Noninvasive Tests for MASLD
The use of altmetrics alongside traditional metrics may contribute to physicians involved in MASLD care obtaining innovative research information on NIT more quickly.
Authors
- Atsushi Nakajima (ORCID: https://orcid.org/0000-0002-6263-1436)
- Masato Yoneda (ORCID: https://orcid.org/0000-0001-7815-549X)
- Yoshio Sumida (ORCID: https://orcid.org/0000-0002-4342-1361)
- Azadeh Hosseini‐Tabatabaei (ORCID: https://orcid.org/0009-0006-6226-5356)
- Hideki Fujii (ORCID: https://orcid.org/0000-0003-1267-9623)
- Hirokazu Takahashi (ORCID: https://orcid.org/0000-0002-2374-2889)
- Shinichi Takeda
Institutions
- Saga University (JP)
- Boehringer Ingelheim (Japan) (JP)
- Boehringer Ingelheim (United States) (US)
- Osaka Metropolitan University (JP)
- Tokyo Metropolitan University (JP)
- Yokohama City University (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Hepatology Research
- Published
- 2025-06-17
- DOI
- https://doi.org/10.1111/hepr.14229
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Boehringer Ingelheim Japan